These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 26430882)

  • 1. Altered Monocyte Phenotype in HIV-1 Infection Tends to Normalize with Integrase-Inhibitor-Based Antiretroviral Therapy.
    McCausland MR; Juchnowski SM; Zidar DA; Kuritzkes DR; Andrade A; Sieg SF; Lederman MM; Funderburg NT
    PLoS One; 2015; 10(10):e0139474. PubMed ID: 26430882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial.
    Serrano-Villar S; Sainz T; Ma ZM; Utay NS; Chun TW; Mann S; Kashuba AD; Siewe B; Albanese A; Troia-Cancio P; Sinclair E; Somasunderam A; Yotter T; Deeks SG; Landay A; Pollard RB; Miller CJ; Moreno S; Asmuth DM
    PLoS Pathog; 2016 Jan; 12(1):e1005381. PubMed ID: 26795282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levels.
    Hey-Cunningham WJ; Murray JM; Natarajan V; Amin J; Moore CL; Emery S; Cooper DA; Zaunders J; Kelleher AD; Koelsch KK;
    AIDS; 2015 May; 29(8):911-9. PubMed ID: 25730509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms in the CD14 gene are associated with monocyte activation and carotid intima-media thickness in HIV-infected patients on antiretroviral therapy.
    Yong YK; Shankar EM; Westhorpe CLV; Maisa A; Spelman T; Kamarulzaman A; Crowe SM; Lewin SR
    Medicine (Baltimore); 2016 Aug; 95(31):e4477. PubMed ID: 27495090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocyte Based Correlates of Immune Activation and Viremia in HIV-Infected Long-Term Non-Progressors.
    Prabhu VM; Singh AK; Padwal V; Nagar V; Patil P; Patel V
    Front Immunol; 2019; 10():2849. PubMed ID: 31867010
    [No Abstract]   [Full Text] [Related]  

  • 6. Infrequent HIV Infection of Circulating Monocytes during Antiretroviral Therapy.
    Massanella M; Bakeman W; Sithinamsuwan P; Fletcher JLK; Chomchey N; Tipsuk S; Chalermchai T; Routy JP; Ananworanich J; Valcour VG; Chomont N
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s.
    Kelesidis T; Tran TT; Stein JH; Brown TT; Moser C; Ribaudo HJ; Dube MP; Murphy R; Yang OO; Currier JS; McComsey GA
    Clin Infect Dis; 2015 Aug; 61(4):651-60. PubMed ID: 25904376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased PD-1 Expression on CD8 Lymphocyte Subsets and Increase in CD8 Tscm Cells in Children with HIV Receiving Raltegravir.
    Tuluc F; Spitsin S; Tustin NB; Murray JB; Tustin R; Schankel LA; Wiznia A; Nachman S; Douglas SD
    AIDS Res Hum Retroviruses; 2017 Feb; 33(2):133-142. PubMed ID: 27615375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD14, CD16 and HLA-DR reliably identifies human monocytes and their subsets in the context of pathologically reduced HLA-DR expression by CD14(hi) /CD16(neg) monocytes: Expansion of CD14(hi) /CD16(pos) and contraction of CD14(lo) /CD16(pos) monocytes in acute liver failure.
    Abeles RD; McPhail MJ; Sowter D; Antoniades CG; Vergis N; Vijay GK; Xystrakis E; Khamri W; Shawcross DL; Ma Y; Wendon JA; Vergani D
    Cytometry A; 2012 Oct; 81(10):823-34. PubMed ID: 22837127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Blood Monocyte Subsets: A New Gating Strategy Defined Using Cell Surface Markers Identified by Mass Cytometry.
    Thomas GD; Hamers AAJ; Nakao C; Marcovecchio P; Taylor AM; McSkimming C; Nguyen AT; McNamara CA; Hedrick CC
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1548-1558. PubMed ID: 28596372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Reduction in Monocyte Activation and Vascular Inflammation With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among HIV-Infected Individuals.
    Hileman CO; Kinley B; Scharen-Guivel V; Melbourne K; Szwarcberg J; Robinson J; Lederman MM; Mccomsey GA
    J Infect Dis; 2015 Aug; 212(3):345-54. PubMed ID: 25583168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased HLA-DR expression on peripheral blood monocytes in subsets of subjects with primary HIV infection is associated with elevated CD4 T-cell apoptosis and CD4 T-cell depletion.
    Gascon RL; Narváez AB; Zhang R; Kahn JO; Hecht FM; Herndier BG; McGrath MS
    J Acquir Immune Defic Syndr; 2002 Jun; 30(2):146-53. PubMed ID: 12045676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen Presenting Cells Contribute to Persistent Immune Activation Despite Antiretroviral Therapy Initiation During Hyperacute HIV-1 Infection.
    Naidoo KK; Ndumnego OC; Ismail N; Dong KL; Ndung'u T
    Front Immunol; 2021; 12():738743. PubMed ID: 34630420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sources of heterogeneity in human monocyte subsets.
    Appleby LJ; Nausch N; Midzi N; Mduluza T; Allen JE; Mutapi F
    Immunol Lett; 2013 Apr; 152(1):32-41. PubMed ID: 23557598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased subpopulations of CD16(+) and CD56(+) blood monocytes in patients with active Crohn's disease.
    Grip O; Bredberg A; Lindgren S; Henriksson G
    Inflamm Bowel Dis; 2007 May; 13(5):566-72. PubMed ID: 17260384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substitution of nevirapine or raltegravir for protease inhibitor vs. rosuvastatin treatment for the management of dyslipidaemia in HIV-infected patients on stable antiretroviral therapy (Nevrast study).
    Calza L; Magistrelli E; Colangeli V; Borderi M; Bussini L; Bon I; Re MC; Viale P
    Infect Dis (Lond); 2017 Oct; 49(10):737-747. PubMed ID: 28683645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of CNS Viral Seeding by HIV
    Veenstra M; León-Rivera R; Li M; Gama L; Clements JE; Berman JW
    mBio; 2017 Oct; 8(5):. PubMed ID: 29066542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals.
    Tippett E; Cheng WJ; Westhorpe C; Cameron PU; Brew BJ; Lewin SR; Jaworowski A; Crowe SM
    PLoS One; 2011; 6(5):e19968. PubMed ID: 21625498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for innate immune system activation in HIV type 1-infected elite controllers.
    Krishnan S; Wilson EM; Sheikh V; Rupert A; Mendoza D; Yang J; Lempicki R; Migueles SA; Sereti I
    J Infect Dis; 2014 Mar; 209(6):931-9. PubMed ID: 24185941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral therapy in HIV-1-infected individuals with CD4 count below 100 cells/mm3 results in differential recovery of monocyte activation.
    Patro SC; Azzoni L; Joseph J; Fair MG; Sierra-Madero JG; Rassool MS; Sanne I; Montaner LJ
    J Leukoc Biol; 2016 Jul; 100(1):223-31. PubMed ID: 26609048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.